The dysregulation of MHC class I processing and presentation, or/and development of IFN-γ insensitivity in tumour cells, would allow tumours to escape from the elimination phase of the cancer immunoediting process (Dunn et al, 2004b). This evidence concerns the gene IFNG and cancer.